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Abstract 
The embryonic heart and vessels are dynamic tissues that form and remodel while 
functional. Much has been learned about the genetic mechanisms underlying the 
development of the cardiovascular system, but we are just beginning to understand how 
changes in heart and vessel structure are influenced by mechanical forces such as 
those derived from fluid flow. Recently, several mutations in mice have indicated that 
vessel remodeling in the yolk sac is secondarily effected when cardiac function is 
reduced or absent. These studies show that proper circulation is required for vessel 
remodeling, but left open questions about whether the role of circulation is to provide 
mechanical cues, to deliver oxygen or to circulate signaling molecules. Here we have 
used time-lapse confocal microscopy to define the role of fluid-derived forces in vessel 
remodeling in the developing murine yolk sac. We have used these tools to characterize 
flows in normal embryos and in embryos with impaired contractility (MLC2a-/-; Huang et 
al, 2003). We found abnormal plasma and erythroblast circulation in these embryos 
which led us to hypothesize that the entry of erythroblasts into circulation is a key event 
in triggering vessel remodeling. We tested this by sequestering erythroblasts in the 
blood islands and found that vessel remodeling depends on erythroblast flow. Further, 
we rescued remodeling defects in these embryos by increasing the viscosity of the 
blood. These data show that fluid-derived forces that depend on viscosity are necessary 
and sufficient to induce vessel remodeling in the mammalian yolk sac.  
Introduction 
The cardiovascular system is the first organ system to develop in vertebrate embryos. In 
the mouse, mesodermally-derived cardiac progenitor cells coalesce at the midline of the 
embryo to form a cardiac crescent, then a linear heart tube that begins to beat by early 
day 8 (Harvey et al., 1999; Ji et al., 2003; Tam and Schoenwolf, 1999). Concurrent with 
the initial formation of the heart, blood and vessels first form in the extraembryonic yolk 
sac.   Primitive erythroblasts and angioblasts can be detected within the blood islands in 
the proximal yolk sac by 7.5 dpc. By 8.5 dpc, a capillary plexus consisting of a polygonal 
network of channels lined by differentiating endothelial cells extends beyond the blood 
islands, covering much of the yolk sac  (Coultas et al., 2005; Drake and Fleming, 2000; 
Ferkowicz et al., 2003; Fraser et al., 2005; Risau and Flamme, 1995). The first 
movements of blood cells mark the onset of blood circulation by the 4-5 somite stage (Ji 
et al., 2003; McGrath et al., 2003), ultimately transporting erythroblasts that differentiate 
in the yolk sac into the embryo. The subsequent development of the heart and blood 
vessels occurs in the presence of blood circulation. Over the next 24 hours chamber 
formation and looping is evident in the heart (Harvey et al., 1999) and the primitive 
vessels of the yolk sac undergo remodeling to form a branched, hierarchical network of 
large and small caliber vessels surrounded by smooth muscle cells (see (Armulik et al., 
2005) for review).  
 Many of the genes necessary for the development of a functional cardiovascular 
system have been identified using large-scale mutagenesis screens or by engineering 
single gene mutations using model systems such as the mouse (Harvey, 1999; Olson, 
2002; Olson and Srivastava, 1996; Solloway and Harvey, 2003) and zebrafish (Stainier, 
2001; Trinh le and Stainier, 2004). The large number of genes necessary for heart and 
vessel development identified in model systems suggests that complex signaling 
mechanisms are required (see(Argraves and Drake, 2005)). In fact, just one aspect of 
development, vascular remodeling in the murine yolk sac, depends on over 50 known 
genes (unpublished observation) including members of the TGF-beta, Notch, VEGF, 
Hedgehog, retinoic acid signaling pathways (see(Argraves and Drake, 2005)).  A clear 
understanding of the role of individual genes can often be hampered by the fact that 
both primary and secondary abnormalities may result from a single gene mutation. For 
instance, abnormal vascular remodeling can result from mutations in genes that 
normally function within endothelial cells or can be caused by mutations in genes 
needed solely for proper cardiac contraction. Null mutations in several genes required 
for cardiac function, including Ncx1 (Koushik et al., 2001; Wakimoto et al., 2000), 
MLC2a (Huang et al., 2003), Nkx2.5 (Tanaka et al., 1999) and Titin (May et al., 2004) all 
result in a failure in yolk sac remodeling despite a lack of expression in endothelial cells. 
Furthermore, vascular abnormalities caused by the deletion of N-cadherin can be 
rescued by cardiac specific expression of either N- or E-cadherin (Luo et al., 2001). To 
explain these effects, it has been proposed that normal blood flow is necessary for 
vascular remodeling. Numerous studies from avian embryos, dating back to well over a 
century ago, support this hypothesis since the surgical manipulation blood flow can lead 
to a wide range of abnormalities in heart and vessel development such as hypoplastic 
left heart syndrome, transposition of the great arteries, atrial and septal defects and 
pharyngeal arch abnormalities (Clark and Hu, 1982; Clark et al., 1984; Clark, 1918; 
Congdon and Wang, 1926; Gessner, 1966; Gessner and Van Mierop, 1970; Harh et al., 
1973; Murray, 1926; Rychter, 1962; Thoma, 1893).   
 While many studies show that blood flow is required for vessel and cardiac 
remodeling, what continues to be debated is the reason why blood flow is important 
(Conway et al., 2003; Coultas et al., 2005; Huang et al., 2003; May et al., 2004). For 
instance, blood flow could be required because it delivers nutrient or oxygen support to 
tissues that are necessary for remodeling. Hypoxic conditions could damage endothelial 
cells directly or alter the levels of necessary growth factors such as VEGF which could 
impair remodeling (Conway et al., 2003; May et al., 2004).  However, early mouse 
embryos (8.5dpc), like early chick, frog and zebrafish embryos, can be cultured in the 
presence of carbon monoxide, which competes for oxygen binding to hemoglobin, 
without effecting the initial stages of vasculogenesis or vascular remodeling (Jones, 
Fraser and Dickinson, unpublished) (Cirotto and Arangi, 1989; Pelster and Burggren, 
1996; Territo and Burggren, 1998), raises questions about the requirement for blood-
derived oxygen.  Even though oxygen delivery may not appear to be critical for some 
events at early stages, it could be argued that early blood flow transports soluble 
nutrients, such as growth factors and cell signaling molecules that are required for 
vascular remodeling (Conway et al 2003). This would mean that circulation would be 
necessary to distribute such a factor, perhaps from a source in the embryo proper to 
more peripheral tissue. A third hypothesis is that circulation imparts force on plexus 
endothelial cells and that this mechanical force is necessary to activate the cell-
signaling cascades necessary for vessel remodeling and continued embryonic 
development. Blood flow exerts two types of force on vessels: shear stress, the frictional 
force tangential to endothelial cells, and circumferential strain, a force perpendicular to 
the direction of flow and related to changes in intravascular pressure.  Numerous 
studies have shown that cultured endothelial cells can perceive these forces and can 
respond by changing morphology, activating intracellular kinases, and inducing gene 
expression (for review, see (Kamiya and Togawa, 1980; Lehoux and Tedgui, 1998; Li et 
al., 2005; Orr et al., 2006; Resnick et al., 2002).  Further support for this hypothesis 
comes from the fact that several factors known to be influenced by shear stress are 
essential for normal cardiovascular development, such as PDGF-β (Resnick et al., 
1993),  connexin43 (Gabriels and Paul, 1998), and Flk1 (Gabriels and Paul, 1998).   
Also, shear stress levels in the mouse yolk sac are within the range known to induce 
gene expression and morphological changes in cultured endothelial cells (Jones et al., 
2004). Despite the circumstantial evidence for flow-derived force in vascular 
remodeling, no direct evidence exists to show that mechanical signals are sufficient to 
drive remodeling or to exclude the possibility that the local oxygen supply or soluble, 
paracrine factors provided through circulation act as a trigger. 
To better understand the role that circulation plays during early embryonic mouse 
development we have used whole embryo culture and time-lapse confocal imaging 
(Jones et al., 2002) to visualize and quantify blood flow in early embryos. We first used 
these methods to analyze the dynamic events at the onset of circulation in normal 
mouse embryos. Next, we characterized aberrant flows in Myosin Light Chain 2a 
(MLC2a) null embryos to understand how secondary remodeling defects are generated 
by impaired contractility. Finally, we tested whether altering the mechanical properties of 
the early blood can phenocopy the vascular remodeling defect seen in MLC2a embryo. 
These studies have revealed that there are two temporal phases of flow during early 
embryogenesis. Slow, but steadily increasing plasma flow is observed, beginning with 
the first heart beats. Erythroblast circulation begins several hours after the heart begins 
to beat and starts with the intermittent flow of individual blood cells. Using the same 
methods, we analyzed flow events in MLC2a mutant embryos and found that both 
phases of blood flow are effected. Early plasma flow is greatly reduced and 
erythroblasts move in an oscillatory, rather than laminar flow pattern, with reduced 
velocity. These results lead us to hypothesize that the laminar flow of erythroblasts is 
necessary for remodeling. To test this, we experimentally manipulated cells within the 
blood islands in early somite embryos to prevent the entry of erythroblasts into the 
circulation, removing the primary viscous component of the blood. Both vascular 
remodeling and embryo turning were impaired when erythroblasts were prevented from 
circulating, showing that the flow of erythroblasts is necessary for remodeling. Normal 
remodeling and turning behaviors were rescued in treated embryos when the viscosity 
of the plasma was increased, showing that mechanical forces are sufficient to induce 
remodeling. Thus, we have used novel methods to analyze and manipulate blood flow 
in early mouse embryos to answer a century-old question about the role of mechanical 
force in vessel remodeling in vivo.  
 
 
Materials and Methods 
Embryo preparation and Time-lapse Microscopy 
Breeding pairs of MLC2a+/-;Tg(є-globin::GFP) mice (Dyer et al., 2001; Huang et al., 2003) were 
mated together and the presence of a vaginal plug in the morning was taken as 0.5 dpc.  
Embryos were collected on the morning of the eighth day and cultured for time-lapse 
microscopy as previously described (Jones et al., 2002).   
 
To investigate changes in erythrocyte flow, single images were taken every 6 minutes at a 
magnification of 20x (Plan-Neofluar 20x/0.5NA) on a Zeiss LSM 5 PASCAL.  Real time images 
of oscillatory motion were taken with 40x magnification, and individual cells were tracked 
manually by connecting the center of the same cell in subsequent images. Overlay of tracking 
images was performed using Adobe Photoshop. 
 
Measurements of plasma flow 
Embryos were removed from the dam at early 8.5 dpc.  They were allowed to recover in 
dissecting media (90% DMEM/F12, 9% fetal bovine serum, 1% pen/strep) for 30 minutes at 
37°C (Jones et al., 2002).  A pulled quartz needle (Sutter Instruments) was filled with 10,000 
MW Texas Red fluorescent dextran (Molecular Probes, No. D-1828) and a picospritzer II 
(General Valve Corp.) was used to inject nanoliter volumes of dye into the heart tube.  Embryos 
were allowed to recover for up to ten minutes and imaged with the Zeiss LSM PASCAL 20x 
magnification to determination of the onset of plasma flow.   
 
Fluorescence Recovery After Photobleaching  
After dissection, embryos were allowed to recover in dissecting media for 30 minutes at 37°C.  
A pulled quartz needle was filled with 50mg/ml, 10,000 MW fluorescein dextran (Molecular 
Probes, No. D-1821) and nanoliter volumes of dye was injected into the heart tube.  Embryos 
were transferred to Nunc Lab-Tek chambers (No. 155380) with culture media (49% DMEM, 
49% DMEM, 1% 1M HEPES, 1% pen/strep) (Jones et al., 2002). The embryos were allowed to 
recover in a tissue incubator at 37C for up to one hour to ensure that dye was present in all 
vessels and that heart rates were normal.   The microscope (Zeiss LSM5 PASCAL or Zeiss 
LSM 510 META) was preheated to 37°C using a heater box (Jones et al., 2002). With a 20x 
lens, an initial image of the plexus was taken, and the location of the bleach recorded.  Scan 
speeds were set to 100 msec per frame and the aperture was set fully open.  The region of 
interest was scanned several times to obtain initial fluorescence levels.  The laser power was 
increased to 100% to bleach and subsequently returned to the original setting for 
measurements. 500-600 frames were collected for each data set.  Embryos were transferred to 
separate wells and somites were counted. 
 
Mean fluorescence with respect to time for the region of interest was tabulated by the LSM 
software and exported to a spreadsheet.  The recovery curve was fit to the equation 
[Soumpasis, 1983]: 
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Where F(t) is the fluorescence intensity, F0 is the initial post-bleach fluorescence intensity, FF is 
the final level of fluorescence recovery, I0 and I1 are zeroth and first order Bessel’s Functions, 
and τ is the characteristic diffusion time.  The bleach area was divided by characteristic diffusion 
time to give the measured diffusion.  The baseline for pure diffusion was obtained by injecting 
embryos with fluorescein-dextran as described, stopping the heart by chilling the embryos at 
4°C for 1 hour, re-heating the embryos to 37°C and performing FRAP.  Absence of heart beat 
was verified prior to measuring FRAP. 
 
Erythroblast  Immobilization 
Embryos were dissected at approximately the 5 somite stage.  A 30% acrylamide/bis-
acrylamide (#161-0158, BioRad) was diluted 1:1 with 2X phosphate buffered saline (PBS) and 
1.2 v/v% ammonium persulfate (stock 20 w/v%) solution was prepared. Blood islands were 
visualized using a Tg(ε-globin-GFP) transgenic line (Dyer et al., 2001) on a fluorescent 
dissecting scope.  The solution was microinjected directly into the blood islands by applying a 
small positive pressure to the injection needle while gently rolling the embryo with the tip of the 
needle. The media was exchanged and the embryos were allowed to recover for approximately 
15 minutes.  The polymerizing agent TEMED (#161-0801, BioRad) was diluted 1:1 with 2X PBS.  
The optimal dilutions for both TEMED and acrylamide were determined via dilution series (data 
not shown), and the combinations producing an instantaneous soft gelatinous matrix with the 
lowest chemical concentration was chosen.  The polymerizing solution was loaded into the 
microinjector pipette and a small positive pressure was applied to create a small fluid stream of 
at the pipette tip.  The tip was then gently touched to the surface of the blood islands to allow 
polymerization of the acrylamide solution.  The media was subsequently changed and the 
embryos were allowed to recover in a standard tissue culture incubator (37°C, 5% CO2) for 30 
minutes before placing them in roller culture in a rat serum rich media (Jones et al 2002) as 
previously described in (Tam, 1998). Three sets of controls were performed: a) uninjected 
embryos, b) embryos injected only with the acrylamide solution, and c) embryos injected with 
only TEMED into the blood islands. 
 
To assess embryo development, yolk sac growth and remodeling, embryos were imaged at the 
same magnification with a Zeiss Axiocam mounted on a Zeiss Lumar stereomicroscope 
equipped for fluorescence imaging.  10,000 MW Texas Red fluorescent dextran (Molecular 
Probes, No. D-1828) injected into the yolk sac vessels (see above) was used to produce a 
fluorescent angiogram to better visualize remodeling. The image scale was calibrated to an 
etched glass standard and the yolk sac perimeter was traced using Zeiss Axiovision software to 
determine the area.  Turning was scored on a scale of 1 to 5 (1=not turned, 5=fully turned) and 
yolk sac vessel remodeling was scored on a scale of 1 to 5 (1=regular polygonal structure 
throughout yolk sac, 5=hierarchical branching pattern of arteries and veins present throughout 
yolk sac). Embryos were randomly assigned a number so that the experimental group was not 
identifiable at the time of scoring and the embryos were matched to their experimental groups 
until after scoring.   
 
Hetastarch Injection 
Hetastarch (Sigma Aldrich, no. H2648) consists of a high molecular weight hydroxyethyl starch 
in a physiologic saline solution (6% in 0.9% NaCl).  Approximately 1-2 hours of recovery after 
TEMED administration, embryos received an intracardiac picoliter injection of Hetastarch, the 
media was changed, and embryos were returned to the incubator.  
 
Results 
Initiation of Blood Flow in Wild-Type Embryos 
Previous studies have shown that erythroblasts enter circulation in a stepwise pattern 
(McGrath et al., 2003). These and other studies (Ji et al., 2003) have examined the 
location of erythroblasts in fixed embryos at different stages to characterize the onset of 
mammalian circulation. With the advent of methods for time-lapse analysis of embryos 
at these early stages (Jones et al., 2002) and the availability of the Tg(ε-globin-eGFP)  
transgenic line in which GFP is expressed within primitive erythroblasts (Dyer et al., 
2001), circulation within the early mouse embryo can be directly visualized using high 
spatial resolution methods. To observe the onset of circulation in mouse embryos, Tg(ε-
globin-eGFP) embryos (n=3) were placed in culture at the 5-6 somite stage (Movie 1, 
Figure 1).  During the first hour, the heart beat is evident but erythroblasts remain 
confined to the blood islands and are not observed in the circulation (Figure 1A, H).  
Occasionally, GFP+ erythroblasts are observed outside the blood islands, often as 
single, stationary cells that are adherent to the walls of the lumen of the capillary plexus 
(Figure 1A, red arrow). It is not clear if these cells differentiated at these sites or if these 
cells were previously transported via plasma flow and have come to rest.  As 
erythroblasts begin to enter the circulation, the hematocrit, or volume percentage of red 
blood cells in vessels, is initially low and fluctuates from one frame to another (Figure 
1B).  Throughout the initiation of circulation, many blood cells flow with a net forward 
motion (Movie 1). Although flow is apparent within most of the vessels, some individual 
erythroblasts become stationary and group together.  In this movie, some groups of 
erythroblasts remain adherent to one another for up to 3 hours (30 frames, Figure 1, 
arrows) before dissociating and rejoining circulation.  Thus, the early circulation of 
erythroblasts is stochastic and intermittent and some cells do not consistently remain 
suspended in the flow.   
 
The onset of circulation is usually defined by the onset of erythroblast circulation.  We 
were interested in determining if significant plasma flow existed prior to the entry of 
erythroblasts into the capillary network vessels.  In agreement with previous findings, 
we detected a beating heart in embryos as early as the 3 somite stage (Navaratnam et 
al., 1986). To test whether enough work was performed by the heart to cause plasma to 
flow from the embryo to the yolk sac, we injected a small volume of fluorescent dextran 
into the hearts of early somite-stage embryos and examined whether the dextran could 
be observed in the yolk sac plexus after a 10 minute incubation period at 37C. In 0 and 
1 somite stage embryos, injected dextran remained confined to the site of injection in 
the heart (n= 4, data not shown). Similarly, dextran was not distributed through the yolk 
sac in most embryos at the 2 somite stage (5 of 6 embryos, Figure 2A-B, D-E). 
However, dextran was consistently found throughout the capillary plexus in 3-somite 
embryos (20 of 20 embryos; Figure 2C,F).  These results show that a continuous 
network between the capillary plexus and the embryo is established at least by the time 
the heart begins to beat and the appearance of dextran in the plexus after such a short 
incubation time suggests that there is significant plasma flow between the embryo and 
yolk sac. 
 
To show that the movement of dextran between the embryo and the yolk was the result 
of circulation and not diffusion,  we measured plasma flow in embryos prior to the entry 
of erythroblasts using Fluorescence Recovery After Photobleaching (FRAP) (for review, 
see (Lippincott-Schwartz and Patterson, 2003)).  Fluorescent Dextran (see materials 
and methods) was injected into the heart tube of 3-8 somite stage embryos. After 
uniform distribution of fluorescent dextran in the yolk sac plexus, a region of interest 
was bleached and the recovery of fluorescence into the bleached area was measured to 
calculate the rate of plasma convection. Initially, we used the FRAP technique to 
measure the rate of diffusion of dextran in plasma using embryos with an arrested heart 
beat (see materials and methods). The diffusion rate was found to be 51 µm2/s ± 7.6, 
n=8 at 37° C. In the presence of the heart beat, even at early stages, we observed 
faster fluorescence recovery of the bleached area and we have termed this 
measurement the perfusion coefficient (Figure 3). At the 3-4 somite stage, the 
measured perfusion coefficients ranged between 100 and 500 µm2/s indicating the 
presence of slow, but significant flow (Figure 3). The variability of plasma flow 
measurements likely relates to the proximity of the measurement site to the heart, as we 
would expect plasma flow to be slower further from the heart and faster where there is a 
shorter, less tortuous path to the heart. Higher perfusion values were measured in later 
stage embryos (5-6 somite stage), and in these embryos, plasma flow in some yolk sac 
regions was too fast to measure by FRAP (indicated by asterisk with arrow). Since the 
circulation system appears to be intact and plasma flow rates increase as embryos 
mature, it is possible that whole blood flow does not begin until blood cells can remain 
suspended by the strength of the flow. Also, these experiments indicate that yolk sac 
endothelial cells are exposed to two different flow regimes in early development, first to 
plasma flow which increases in velocity steadily during early somite stages, followed by 
the circulation of erythroblast-containing blood beginning at 5-7 somites.  
 
Erythroblast Circulation in MLC2a -/- embryos 
Null myosin light chain 2a mice exhibit defects in atrial contraction and ventricle filling as 
well as in vascular remodeling (Huang et al., 2003), making this mutant an excellent 
model to study the relationship between circulation and remodeling. To observe 
circulation directly, MLC2a mutant mice were crossed with Tg(ε-globin-eGFP) mice 
(Dyer et al., 2001). Confirming previous findings, fluorescence images of fixed MLC2a-/-
; Tg(ε-globin-eGFP) embryos  show that vascular remodeling is impaired (Figure 4).  
MLC2a-/-; Tg(ε-globin-eGFP) are indistinguishable from wildtype or heterozygous 
littermates at 8.5 dpc; However, by 9.5 dpc MLC2a-/- null embryos still have an 
unremodeled capillary plexus while MLC2a +/+ and +/- embryos show a patterned 
vasculature with a hierarchical arrangement of large and small caliber vessels.   
 
Although 8.5 dpc embryos appeared phenotypically indistinguishable from the wild type 
littermates, we hypothesized that the deficient yolk sac remodeling observed at 9.5 dpc 
was due to altered flow patterns occurring at 8.5 dpc.  Thus, we characterized 
circulation in 8.5 dpc MLC2a-/- embryos.  First, to determine if the onset of circulation is 
delayed in MLC2a-/- embryos compared to heterozygous or wildtype littermates, we 
examined embryos dissected at various somite stages to assess capillary plexus 
morphology and maturation (Table I).  By the 10 somite stage, erythroblasts are 
routinely found throughout the plexus in wild-type and heterozygous embryos but 
erythroblasts were not seen consistently throughout the whole plexus until 12-13 
somites in the MLC2a-/- embryos.  Thus, the onset of erythroblast circulation appeared 
to be slightly delayed in MLC2a-/- embryos. 
 
Next, we used time-lapse confocal microscopy to directly observe blood cell movement 
in MLC2a-/- embryos. Our time lapse data from wild-type embryos has shown that 
erythroblasts enter circulation in an intermittent fashion, with the majority of cells flowing 
with a net forward motion (Figure 1, Movie 1). Blood flow in the late 8.5 dpc yolk sac is 
typically pulsatile and fits a laminar profile (Jones et al., 2004). In contrast, time lapse 
sequences from similarly staged MLC2a-/- embryos showed that forward flow of 
erythroblasts was impaired. Erythroblasts were either stationary (data not shown) or 
moving in an oscillatory pattern, where there was an equal amount of retrograde and 
anterograde motion (Figure 5, Movie 2). Oscillatory motions of erythroblasts could easily 
be tracked from frame to frame using time lapse data acquired at 2 frames/sec (Figure 
5B) because blood cells only move 3-5 cell diameters every 500ms, whereas the 
velocity of flowing erythroblasts in wild type yolk sacs must be measured using high 
speed methods and ranges from 0.5 to 6 mm/s at this stage (Jones et al., 2004).  Thus, 
instead of the normal fast, laminar flow pattern seen in wild type embryos, slow, 
oscillatory flow was observed in MLC2a-/- embryos.  
 
To determine if the deviation from normal flow patterns were present prior to 
erythroblast entry into the circulation, we examined plasma flow in MLC2a-/- embryos 
using the FRAP technique.  The measured perfusion coefficients are comparable 
between wild-type (Figure 3) and knock-out littermates at the 3 and 4 somite stages 
(data not shown), but by 6-9 somites, MLC2a-/- embryos show reduced plasma flow as 
compared to wild type littermates (Figure 6). By this stage, we have measured perfusion 
coefficients as high as 3835 µm2/s in wild type embryos (n=23) and often encounter 
regions with flow too fast to measure, whereas in knock-out embryos, all measured 
perfusion coefficients were nearly four times lower (below 1045 µm2/s; n=28) and no 
vessels exhibited flow outside the measurable range.  Of note, the perfusion coefficients 
measured in MLC2a-/- embryos are an order of magnitude larger than pure diffusion (51 
µm2/s ± 21), indicating that plasma flow is present, but weak. These data show that poor 
cardiac function can be detected in very early mutant embryos, soon after the heart 
begins to beat and before any other phenotype is present. 
 
Vascular remodeling requires fluid derived forces   
 
Our high-resolution analysis of circulation in wildtype and mutant embryos revealed that 
there are two distinct types of flow during early cardiovascular development, a period of 
plasma flow, followed by the entry of erythroblasts into circulation, resulting in whole 
blood flow. In MLC2a-deficient embryos, both of these phases show reduced velocity, 
but from these data we cannot discern which function afforded by circulation is critical 
for vascular remodeling. Reduced plasma flow could limit the circulation of soluble 
factors and nutrients in embryonic and extraembryonic tissues.  If soluble factors were 
sufficient to induce remodeling, restoring normal plasma flow alone should rescue 
remodeling. Alternatively, both oxygen transport and mechanical force depend on the 
hematocrit and if these are essential elements of the circulation than normal plasma 
flow alone would not be sufficient to stimulate remodeling and the circulation of blood 
cells would be needed.  Poor circulation of blood cells could increase hypoxia which 
could damage endothelial cells and inhibit remodeling. Alternatively, blood cell 
circulation could provide a necessary mechanical stimulus. Suspended particles in 
blood flow, such as erythroblasts, increase the overall effective viscosity of the blood 
(Chien et al., 1966) and mechanical forces such as shear stress depend on the 
apparent viscosity of the fluid. Therefore, we tested the role that erythroblasts play in 
vascular remodeling by experimentally sequestering blood cells within the blood islands 
during development. By reducing the hematocrit and the effective viscosity of the blood, 
without affecting plasma flow velocities we could determine if soluble factors in the 
plasma were sufficient for remodeling. To do this, we used focal applications of a 
polymerizing gel to immobilize the cells within the blood islands prior to the initiation of 
erythroblast circulation. Experiments were performed using Tg(ε-globin-eGFP) embryos 
to visualize the blood islands and monitor the extent of erythroblast circulation (Figure 7 
C,F,I). Treated embryos were allowed to develop for 24h in roller culture and were 
subsequently assessed for vascular morphology, expansion of the yolk sac and the 
incidence of embryonic turning (see materials and methods).  Controls were performed 
to ensure that each of the components of the polymer solutions were not toxic to 
embryos (Table 2).  
 
In control and untreated embryos, a hierarchical vascular branching pattern with 
enlarged avascular spaces was observed in yolk sacs after 24h in culture (Figure 7, 
Table 2). Erythroblasts were robust in number and uniformly distributed within the 
vascular space (Figure 7C). When erythroblasts were prevented from leaving the blood 
islands, vascular remodeling did not take place (Table 2; Figure 7D,E,F). While control 
embryos formed the characteristic large and small caliber branched vessels, embryos 
with lowered hematocrit did not form any large vessels, only an immature plexus was 
observed in these embryos (Table 2;Figure 7E). In addition, embryos receiving this 
treatment grew and the yolk sac expanded, but the embryos did not turn (Table 2; 
Figure 7D,E,F). Occasionally, it appeared as if the initial steps in remodeling had 
occurred, characterized by the presence of elongated vascular tubes, but large diameter 
vessels were never evident (Table 2).  We attribute the slight variability in the vessel 
phenotype to variations in the extent of the gel treatment. Although most erythroblasts 
were immobilized, a small number of erythroblasts were often found in circulation 
following the treatment (see 7F). Gel treatment of the blood islands did not affect 
plasma flow in treated embryos. Plasma flow rates were comparable to normal, 
untreated embryos (Figure 8), indicating that the velocity of blood flow is not reduced.  
Thus, we conclude that the circulation of plasma alone is insufficient to drive vascular 
remodeling, arguing against the idea that vascular remodeling is triggered by a soluble 
factor carried by blood flow.  
 
The above experiments show that the flow of erythroblasts is necessary for remodeling, 
but it is not clear whether remodeling requires the presence of blood cells for proper 
oxygenation or because of the mechanical force that is imparted by viscous flow. High 
molecular weight, synthetic sugars derived from plants, such as hetastarch, have been 
shown to increase the viscosity of solutions (Akers and Haidekker, 2004; Haidekker et 
al., 2002). Therefore, we injected a hetastarch solution into the circulation of embryos 
with sequestered blood cells to determine if raising the viscosity of the plasma could 
rescue the remodeling phenotype caused by the absence of circulating erythroblasts. 
We found that embryos treated with polymerizing gel and injected with hetastarch had 
clearly visible large, branched yolk sac vessels (Figure 7G,H,I), and were 
indistinguishable from wild type in terms of the size of the yolk sac (Table 2). Even 
embryo turning was restored in most cases when the viscosity of the blood was 
increased (Table 2). Thus, increasing the viscosity was sufficient to rescue the 
remodeling deficiency.  These data show that mechanical force provides a signal 
responsible for triggering vascular remodeling in the yolk sac. Vascular remodeling can 
occur in the absence of blood cell circulation if the viscosity of the blood is adjusted to 
account for the drop in hematocrit showing that oxygen transport from the blood cells is 
not necessary for remodeling to take place. These data show that mechanical force is 
both necessary and sufficient to trigger vascular remodeling in the yolk sac of early 
mouse embryos.  
 
Discussion 
 
 
Physical forces imparted by blood flow are necessary and sufficient to induce 
vascular remodeling in the yolk sac 
 
The main goal of these studies was to investigate the role of fluid-derived forces in 
vessel remodeling in an in vivo model system, the mouse embryo yolk sac. First, we 
characterized the onset of plasma and erythroblast flow to reveal the sequence of early 
events at the onset of circulation. Next, we examined plasma and erythroblast flow in 
mutants with impaired heart contractility to determine the flow patterns associated with 
poor yolk sac vascular remodeling. These two sets of investigations led us to formulate 
the hypothesis that the increase in apparent viscosity that occurs when blood cells enter 
the circulation results in a physical stimulus that triggers remodeling. We tested this 
hypothesis by first preventing blood cells from entering circulation. This treatment 
lowers the hematocrit and reduces the apparent viscosity of the blood. We found that 
sequestering the blood cells prevented vascular remodeling and embryo turning. These 
data showed that circulating blood cells were necessary for vascular remodeling, but we 
could not conclude that this effect was due to an alteration of the mechanical properties 
of the blood. Therefore, another set of experiments were performed in which blood cells 
were prevented from entering circulation but were replaced by injecting a plant starch to 
increase the viscosity of the plasma. This treatment rescued vascular remodeling and 
turning; therefore, changes in the viscosity of the blood, and hence the physical force 
exerted by the blood, is sufficient to induce vascular remodeling and embryonic turning 
in early mouse embryos. Since prolonged plasma flow was not sufficient to induce 
remodeling and remodeling could be triggered in the absence of oxygen carrying blood 
cells, we can firmly conclude that mechanical force, rather than soluble factors or 
changes in oxygen supply, provides the critical signal for vascular remodeling in the 
early mouse embryo. 
 
Our work clearly shows that the mechanical force exerted by blood flow imparts an 
important signal for triggering vascular remodeling, although precisely which forces are 
most important for vascular remodeling remain an open question since both shear 
stress and circumferential strain could be instructive. Shear stress, the frictional force 
exerted by blood flow is directly dependant on the apparent viscosity of the fluid and is 
likely to be a critical force acting on early endothelial cells. Shear stress has been 
shown to induce changes in gene expression, cytoskeletal architecture and cellular 
dynamics, including proliferation, in cultured endothelial cells (Garcia-Cardena et al., 
2001; Helmke, 2005; Li et al., 2005; Orr et al., 2006; Resnick et al., 2002). Our previous 
research has shown that shear stress can be as high as 6 dyn/cm2 in the mouse yolk 
sac during the first day of erythroblast circulation, within the range known to induce 
changes in cell morphology and upregulate shear stress responsive genes (Jones et al., 
2004). Others have shown that non-erythroid, murine yolk sac cells extend cellular 
projections in the absence of flow but cease in the presence of low shear stress (1 
dyn/cm2) (Blatnik et al., 2005) and May et al (2004) have shown that endothelial cells in 
Titan mice, which have deficiencies in cardiac contraction, are not aligned along the 
vessel wall, suggesting a lack of sufficient shear stress. Despite the evidence 
supporting a role for shear stress, we cannot clearly state that shear stress is the only 
essential force at work in this system since circumferential strain may also play an 
important role in early development. Many experiments show that both types of force 
can induce similar physical and molecular changes in cultured endothelial cells (Lehoux 
and Tedgui, 1998; Kamiya and Togawa, 1980; Lie et al 2005; Orr et al 2006) and 
presently, we cannot distinguish a separate role for the two different types of force. 
 
The initiation of murine blood circulation 
 
Our analysis of flow in the early yolk sac indicates that erythroblast circulation is 
preceded by several hours of plasma flow, beginning as soon as the heart begins to 
beat. While some sources have described a patent heart tube that is present by 6 
somites (See Ji et al 2003 and references therein), our experiments show that there is a 
functional connection between the heart and yolk sac vessels that is capable of 
supporting plasma flow by the time the heart begins to beat at 2-3 somites. Initially 
plasma flow is slow, but significantly faster than diffusion, and increases in strength 
during early somite stages.  
 
During the initial stages of circulation when blood consists of plasma alone, we suspect 
that endothelial cells are exposed to very low shear stress; however, we have not yet 
been able to measure shear stress exerted by plasma flow. Although these forces are 
insufficient to initiate remodeling, low levels of shear stress may influence early 
endothelial cells in other ways. Interestingly, recent evidence indicates that shear stress 
as low as 1.5 dyn/cm2 can stimulate the differentiation of Flk-1+ cells in ES cell culture 
assays (Yamamoto et al., 2005) and can reduce the motility of yolk sac cells (Blatnik et 
al., 2005). Thus, it is possible that the initial period of plasma flow helps to facilitate the 
formation of endothelial cells or reduce the motility of endothelial cells so that they can 
form stable vessel networks. Further experiments will be needed to determine if plasma 
flow alone plays a specific in vivo role. 
 
Plasma flow steadily increases during early somite stages and a small number of blood 
cells enter into circulation beginning at the 5-6 somite stage. We believe that blood cells 
begin to enter the circulation once sufficient force is generated by the flow to initiate 
blood cell movement and keep cells suspended. It is not clear whether the increase in 
force provided by stronger plasma flow is the only significant factor to influence the 
initial movement of blood cells. It is also possible that changes in cell adhesion between 
erythroblasts and surrounding cells facilitates erythroblast circulation, although this has 
not been investigated directly here. 
 
Previous studies have investigated the onset of circulation in mouse embryos by 
examining the location of erythroblasts in fixed embryos (Ji et al., 2003; McGrath et al., 
2003) and by assessing blood flow in the heart and dorsal aorta using high-resolution 
ultrasound (Ji et al., 2003; Phoon et al., 2000; Phoon et al., 2002). We have extended 
these studies by examining the movement of GFP-labeled erythroblasts directly in 
developing embryos using time-lapse confocal microscopy.  We show that when 
primitive blood cells begin to move through the capillary plexus, they are not 
consistently suspended in the flow and can come to rest, even adhering to cells that line 
early vessels. Interactions between individual blood cells and the walls of the 
microvessels in the plexus can increase the apparent viscosity by increasing the 
resistance to flow (see (Fung, 1997), Chapter 1.8, p13). Thus, it is likely that the forces 
exerted on individual endothelial cells may be quite diverse in different 
microenvironments within the plexus due to the particulate nature of the blood and the 
interactions between blood and endothelial cells. Given the potential for these types of 
interactions, it is interesting that vascular remodeling can be induced by changing the 
viscosity using a non-particulate suspension. These data indicate that the specific 
interactions between blood and endothelial cells may not be as important for vascular 
remodeling as the overall change in viscosity that occurs when the hematocrit 
increases. 
 
Impaired circulation in MLC2a mutant embryos 
 
Hemodynamic deficiencies in MLC2a mutant mice were quantitatively assessed using a 
combination of fluorescent transgenic marker strains and time-lapse confocal 
microscopy. By examining GFP+ erythroblasts in MLC2a null embryos, we observed 
that erythroblasts fill the yolk sac plexus, but at a slightly later stage than in wild type 
embryos. Without the benefit of time-lapse analysis, one might conclude that there was 
only a minor flow abnormality in these embryos, but time-lapse data of 11 somite 
MLC2a-/- embryos revealed that severe flow abnormalities were present. Instead of 
flowing in a pulsatile, forward pattern, erythroblasts in mutants oscillated back and forth 
with little net forward motion. We concluded that the slow oscillatory flow is sufficient to 
distribute blood cells from the blood islands into more proximal regions of the plexus, 
but insufficient to induce remodeling. Thus, time-lapse analysis was critical in 
understanding the nature of the flow deficiency present in mutant embryos.  
 
Since blocking the flow of erythroblasts in wild type embryos phenocopies the 
remodeling defect seen in MLC2a mutant embryos, it is likely that remodeling fails 
because erythroblasts do not establish a normal laminar flow pattern, reducing the force 
exerted by the flow. Alternatively, it is possible that the change in the flow pattern from 
laminar to oscillatory could also play a significant role. Culturing mouse embryos in KB-
R7943, an NCX1 inhibitor, reduces cardiac function and leads to impaired yolk sac 
plexus remodeling (unpublished data). Blood cells do not oscillate back and forth, but do 
exhibit severely reduced motion suggesting that the reduced motion of erythroblasts, 
regardless of the pattern of flow, is to blame for the remodeling phenotype. It is not 
known whether the oscillations in MLC2a embryos have any effect on local endothelial 
cells. Cell proliferation, which is thought to be enhanced by oscillatory flow patterns 
(Chiu et al., 1998; Davies et al., 1986; Levesque et al., 1990), is similar between MLC2a 
and wildtype embryos (data not shown).  
 
The oscillatory flow seen in MLC2a mutant embryos can be attributed to altered cardiac 
contraction. Although MLC2a RNA is expressed throughout the heart tube at 7.5dpc 
(Kubalak et al., 1994), MLC2a protein is only incorporated into atrial myofibrils (Chen et 
al., 1998). We believe that the oscillatory motion is due to the mismatch between the 
functional ventricle and the impaired atrium. In the absence of atrial contraction, net 
formward motion of the blood cannot be maintained. Thus, even though a clear 
morphological distinction between compartments is not evident in the mutant embryos 
at this stage (Huang et al., 2003), functional differences between the compartments can 
be detected by observing the blood flow pattern. Also, since poor plasma circulation is 
seen as early as 6-9 somites, it is clear that atrial contraction plays an important role in 
blood circulation very soon after the heart begins to beat.  
 
Blood flow and embryo turning 
 
Our analysis of hemodynamics in early mouse embryos has led to the interesting 
conclusion that proper blood flow is required for embryo turning.  Although it is not 
entirely clear why embryos do not turn when circulation is impaired, we suspect that 
poor or absent circulation changes the tension within the yolk sac as it expands which 
could impair turning.  Similar effects on turning were observed in MLC2a-deficient 
embryos (data not shown), however we are not aware whether this is a common feature 
of mice with hemodynamic deficiencies since it generally not reported. The yolk sac of 
embryos treated to sequester the blood cells are slightly smaller than control embryos, 
indicating that the yolk sac has not expanded completely. In our initial analysis of 
optimal culture conditions for growing embryos in culture, we also noticed that turning 
was impaired when the yolk sac did not expand well (Jones et al 2002; unpublished 
observations). Alternatively, the lack of blood flow in the embryo proper may also be 
responsible for poor turning. At present little is known about how the mechanical forces 
needed for turning are generated within the embryo and surrounding tissues. Further 
investigations are needed to better understand the role of circulation. 
 
The mechanical role of erythroblasts has been elusive 
The role of primitive erythroblasts in early embryonic development has been difficult to 
ascertain. Mutations in several genes alter the development of blood cells in the early 
embryo, but other cell types are also affected. For instance, null mutations in E T-mod 
alters the mechanical properties of primitive erythroblasts; however, E T-mod embryos 
also have a defect in cardiac contractility that impairs circulation (Chu et al., 2003), so it 
is not known if altering blood cell structure could impair remodeling.  Our data implies 
that anything that would affect the rheology of the blood cells would also cause 
remodeling to be abnormal. Also, many mutations that impair hematopoiesis in 8.5dpc 
embryos also alter angioblast differentiation and/or function (Oike et al., 1999; Oshima 
et al., 1996; Robb et al., 1995; Shalaby et al., 1995; Shivdasani et al., 1995; Suri et al., 
1996).  For instance, in Tal1/SCL mutants, hematopoeisis is severely impaired as 
embryos lack primitive erythroblasts and have defects in vascular remodeling (Robb et 
al., 1995; Shivdasani et al., 1995); however transgenic rescue and chimera experiments 
show Tal1/SCL is essential in endothelial cells for proper vascular remodeling (Visvader 
et al., 1998). It is suspected that severe anemia alone would also be sufficient to induce 
the same phenotype, but these conditions have never been encountered in genetically 
engineered embryos at such early stages.  
 
The genetic basis for vascular remodeling 
Recently, there have been great strides in identifying the molecular components of a 
shear stress transduction pathway, implicating many molecules that are expressed 
during vasculogenesis and vessel remodeling.  Shear stress is thought to be sensed by 
PECAM-1, VE-Cadherin and VEGFR2 (Flk1) (Tzima et al., 2005) at the membrane 
which leads to the activation of c-Src (Jalali et al., 1998; Okuda et al., 1999) and the 
conversion of Integrins to high affinity forms (Tzima et al., 2002; Tzima et al., 2001; 
Tzima et al., 2003). Furthermore, Kruppel-like factor-2 (Klf2) has been shown to be 
upregulated in response to shear stress and a necessary transcription factor for the 
expression of flow regulated genes (Dekker et al., 2006; Dekker et al., 2005; Parmar et 
al., 2006). However, due to redundancies and earlier functions, mutant analysis has 
gleaned only limited information about the mechanisms of vessel remodeling. 
Surprisingly, PECAM-1 knock out mice are viable to adulthood (Duncan et al., 1999) 
suggesting that there may be functional redundancy in this pathway in vivo. VEGFR2 
plays an earlier role in the differentiation of blood and endothelial cells (Shalaby et al., 
1997; Shalaby et al., 1995) making it difficult to understand  how it is involved in shear 
stress signaling, and Klf2-deficient embryos undergo vessel remodeling, but later in 
gestation have defects in vessel stability (Kuo et al 1997). Interestingly, VE-Cadherin-
deficient embryos fail to remodel the initial vascular plexus (Carmeliet et al., 1999; Gory-
Faure et al., 1999), which would be predicted based on the data shown here if 
endothelial cells could not properly sense shear stress. Instead of undergoing 
remodeling, endothelial cells become detached from each other and the basement 
membrane, and undergo apoptosis (Carmeliet et al., 1999). Although these data are 
consistent with a role in transducing mechanical signals in vivo, it is also possible that 
vascular remodeling fails because many endothelial cells die (Carmeliet et al., 1999). 
Further investigation is needed to determine if there is more direct evidence to implicate 
VE-Cadherin in shear stress-induction, such as whether shear stress-induced genes are 
abnormally regulated in yolk sac cells. 
 
Conclusion 
In this study, we have used novel methods to define a role for fluid derived mechanical 
signaling during embryonic development. By generating methods to manipulate the 
physical properties of the early blood, we were able to show that the material properties 
of the blood may be more important than the metabolic function that blood plays later in 
development. Strategies such as these show the strength of combining both genetic 
and physiological methods to understand complex cardiovascular phenotypes and open 
the door to further investigation of shear stress signaling in vivo.
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Tables 
Table 1 – Expansion of Blood Islands and Erythroblast Circulation: Comparison between wild type and MLC2a-/- Embryos. 
 
Somite stage 4 5 6 7 8 9 10 11 12 13 14-15 
Blood Islands Only 8 11 10       4               
Expansion proximal to blood islands 4 11 15 19 14     13 4         
Full plexus      2       5 10 12 14 12 11 12 17
+/+ 
& 
+/- 
n= 12 22 27 28 24 25 18 12 11 12 17
             
 Somite stage 4 5 6 7 8 9 10 11 12 13 14-15 
Blood Islands Only 6 4 2 5  1   1         
Expansion proximal to blood islands 1   4 2 6 4 3  4              1 
Full plexus           2       5 2
-/- 
n= 7 4 6 7 7 6 4 4  5 3 
 
 
Table 2 – Quantitative Analysis of Growth, Embryo Turning and Yolk Sac Vessel Remodeling in Treated Embryos.  
 
Treatment n Area (mm2) Turn Score 
Remodel 
Score 
Control 23 5.23 ± 0.19 3.78 ± 0.32 4.13 ± 0.30
Low Hematocrit. 41  4.06 ± 0.12*  1.70 ± 0.15*  1.76 ± 0.16*
Low Hematocrit + Hetastarch 19 5.19 ± 0.28 2.68 ± 0.32 3.58 ± 0.30
Acrylamide only 5 4.93 ± 0.41 3.80 ± 0.49 4.20 ± 0.49
TEMED only  14 5.93 ± 0.28 4.00 ± 0.36 4.64 ± 0.20
Hetastarch only   12 6.05 ± 0.24 3.50 ± 0.44 4.25 ± 0.37
Figure Legend 
 
Figure 1 – Initiation of Erythroblast Circulation.  The initiation of erythroblast circulation 
was followed using time-lapse microscopy (Movie2) in a 6-somite mouse embryo 
expressing erythroblast specific GFP.  The yolk sac (YS), and the heart (H) and somites 
(S) can be seen.  Erythroblasts enter circulation within 11 frames.  Some newly 
circulating  erythroblasts exit the flow stream and remain stationary for various periods of 
time (arrows).  Images were taken every 6 minutes at 10x magnification on a Zeiss 
LSM5 PASCAL for a total of 12.1 hrs.   
Figure 2 – Initiation of Plasma Flow.  10,000MW fluorescent dextran was injected into 
the heart (Hrt) of early mouse embryos.  The embryos were incubated for 10 minutes 
and images were taken using a Zeiss LSM5 PASCAL microscope at 5x magnification.  
The presence of fluorescence in the yolk sac after such a short incubation was 
interpreted as the result of flowing blood plasma.  In most 2-somite embryos (5 out of 6 
injected embryos), dextran remains localized to the heart (A and B; arrow in B).  In one 
observed case, however, fluorescent dextran could be observed in the proximal yolk sac 
(ys) (C and D; arrow in D).  Plasma circulation is consistently observed at the 3 somite 
stage onward (data not shown).  A, C are images taken with brightfield illumination 
overlaid with fluorescence images of fluorescent-labeled dextran within the vessels 
(fluorescent microangiographs), B,D are the microangiographs only.  
Figure 3 – Perfusion Coefficients of Wild-Type Embryos Measured using FRAP.  
Plasma flow magnitude in the early capillary network was determined between somite 
stages 3 and 8 by calculating a perfusion coefficient using Fluorescence Recovery After 
Photobleaching (FRAP).  The upper range of perfusion coefficients increases as 
cardiogenesis progresses and at the 6 somite stage and later, flows too fast to measure 
are observed (asterisk and arrow).  We observed a range of values even within a given 
embryo since flow was reduced at sites farther from the heart.  
Figure 4 – Phenotype of MLC2a-/- Embryos.  Heterozygous (A, C, E) and knock-out (B, 
D, F) littermates at the 7 somite (A-B), 10 somite (C-D) and approximately 23 somite 
stage (9.5 dpc) (E-F).  The capillary plexus is demarcated via GFP-expressing 
erythroblasts.  In the knockout embryos, blood islands form (A,B) and erythroblasts enter 
the circulation (C,D), indicating that vascular development in MLC2a -/-  embryos is not 
impaired through the 10 somite stage .  However the plexus retains the immature 
phenotype and fails to remodel by embryonic day 9.5 in the mutant embryos (E,F) (F). 
Figure 5 – Erythroblast Motion in MLC2a-/- embryos.  The motion of erythroblasts 
(green) within vessels of MLC2a-/- embryos was imaged at 2Hz using a 40x objective 
lens on a Zeiss LSM5 PASCAL. Panels represent every 5th frame.  The motion of 
individual erythroblasts were tracked and plotted (B), illustrating that erythroblasts 
oscillate with as much retrograde motion as anterograde.   
Figure 6 – Perfusion Coefficients of Embryos with Impaired Cardiac Function.  
Fluorescence Recovery After Photobleaching (FRAP) was used to calculate perfusion 
coefficients within the early embryonic blood vessels in MLC2a-/- embryos and wild type 
embryos at the 6-9 somite stage.  Perfusion coefficient ranges were significantly lower 
mutant embryos compared to wild type embryos. While some coefficients in wildtype 
embryos were too fast to measure, all flows could be measured in mutant embryos. The 
average measured flow rate was 1601±267 μm2/s for control embryos and 312 ± 47 
μm2/s for MLC2a-/- embryos.  
Figure 7 – Plasma Viscosity Alters Yolk Sac Remodeling.  Embryos were harvested at 
8.25 dpc, placed in roller culture for 24 hours, and injected with red fluorescent dextran 
to create a fluorescent microangiograph (B,E and H).  Control embryos turned (A) and 
yolk sac vessels remodeled into a hierarchical, branched phenotype (B).  A substantial 
eGFP-positive erythroblast population was evident in all parts of the yolk sac vasculature 
(C).  Embryos with erythroblasts sequestered in the blood islands often did not turn but 
continued to develop after 24 hours in culture conditions (D).  The yolk sac vasculature 
did not remodel and retained features of an immature plexus (E).  Erythroblasts 
remained confined to the site of the blood islands (F).   Embryo turning was restored (G) 
and yolk sac remodeling was rescued (H) in embryos with sequestered erythroblasts (I) 
after injection of Hetastarch.  Scale bar = 50µm. 
Figure 8 – Perfusion Coefficients in Embryos Experiencing Low Viscosity.  Fluorescence 
Recovery After Photobleaching (FRAP) was used to calculate perfusion coefficients for 
the plasma motion in wild-type embryos and embryos with erythroblasts sequestered in 
the blood islands.   The perfusion coefficient ranges and mean values were similar in 
wild-type and polymerized embryos, indicating that plasma velocity is normal following 
the treatment to sequester the erythroblasts.   
 
Figure 1 
 
Figure 2 
 
Figure 3 
Somite Stage
2 3 4 5 6 7 8 9
0
1000
2000
3000
4000
5000
Pe
rf
us
io
n 
C
oe
ff
ic
ie
nt
 μm
2 /
s
? ? ?
 
Figure 4 
Figure 5 
 
 
 
 
 
Figure 6 
 
Wild Type MLC2a
Pe
rf
us
io
n 
C
oe
ffi
ci
en
t μ
m
2 /
s
0
1000
2000
3000
4000
5000
?
 
 
Figure 7 
 
 
 
 
 
 
Figure 8 
 
Control Low Hct
Pe
rf
us
io
n 
C
oe
ff
ic
ie
nt
 μm
2 /s
0
1000
2000
3000
4000
5000
? ?
 
